FDA Inspection
CKD Bio CorporationCKD Bio Corporation – FDA Inspection, Oct 26, 2018
Record Details
This FDA Inspection record concerns CKD Bio Corporation, with an inspection on October 26, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a171cc5b-8308-48b2-8e6e-929b61e9d5b6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1069932
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of CKD Bio Corporation
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | VAI | Drug Quality Assurance | |
| September 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 18, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 17, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CKD Bio Corporation
- FDA Inspection 1299998 - 2025-11-07
- FDA Inspection 1287766 - 2023-09-15
- FDA Inspection 1195625 - 2022-11-18
- FDA Inspection 956322 - 2015-12-17
- FDA Inspection 773987 - 2012-03-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.